2019 Gestational Diabetes Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Gestational Diabetes Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Gestational Diabetes. It presents in-depth analysis of Gestational Diabetes clinical trials across markets and companies. The research work is for providing complete understanding into trends in Gestational Diabetes.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Gestational Diabetes clinical trials by-
The research work is prepared through extensive and continuous research on Gestational Diabetes trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Gestational Diabetes clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Gestational Diabetes trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Gestational Diabetes patients are identified
- The report includes panorama of Gestational Diabetes clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Gestational Diabetes clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Gestational Diabetes Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Gestational Diabetes Clinical Trials by Region
2.2.2 Average Enrollment of Gestational Diabetes Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Gestational Diabetes Treatment, 2019
3. REGION WISE GESTATIONAL DIABETES CLINICAL TRIALS
3.1 Asia Pacific Gestational Diabetes Clinical Trials by Country
3.2 Europe Gestational Diabetes Clinical Trials by Country
3.3 North America Gestational Diabetes Clinical Trials by Country
3.4 Middle East and Africa Gestational Diabetes Clinical Trials by Country
3.5 South and Central America Gestational Diabetes Clinical Trials by Country
4. GESTATIONAL DIABETES CLINICAL TRIAL TRENDS
4.1 Start Year wise Gestational Diabetes Clinical Trials
4.2 Phase wise Gestational Diabetes Clinical Trials
4.3 Trial Status wise Gestational Diabetes Clinical Trials
4.4 Trial Type wise Gestational Diabetes Clinical Trials
5. GESTATIONAL DIABETES AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Gestational Diabetes Trials by Year
5.2 Average Enrollment in Gestational Diabetes Trials by Phase
5.3 Average Enrollment in Gestational Diabetes Trials by Status
5.4 Average Enrollment in Gestational Diabetes Trials by Type of Trial
6. COMPANIES PARTICIPATING IN GESTATIONAL DIABETES CLINICAL TRIALS
6.1 Gestational Diabetes Trials by Sponsor Type
6.2 Gestational Diabetes Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Gestational Diabetes Trials- Phase
7.2 Gestational Diabetes Trials- Phase
7.3 Gestational Diabetes Trials- Phase
7.4 Gestational Diabetes Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Gestational Diabetes Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Gestational Diabetes Clinical Trials by Region
2.2.2 Average Enrollment of Gestational Diabetes Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Gestational Diabetes Treatment, 2019
3. REGION WISE GESTATIONAL DIABETES CLINICAL TRIALS
3.1 Asia Pacific Gestational Diabetes Clinical Trials by Country
3.2 Europe Gestational Diabetes Clinical Trials by Country
3.3 North America Gestational Diabetes Clinical Trials by Country
3.4 Middle East and Africa Gestational Diabetes Clinical Trials by Country
3.5 South and Central America Gestational Diabetes Clinical Trials by Country
4. GESTATIONAL DIABETES CLINICAL TRIAL TRENDS
4.1 Start Year wise Gestational Diabetes Clinical Trials
4.2 Phase wise Gestational Diabetes Clinical Trials
4.3 Trial Status wise Gestational Diabetes Clinical Trials
4.4 Trial Type wise Gestational Diabetes Clinical Trials
5. GESTATIONAL DIABETES AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Gestational Diabetes Trials by Year
5.2 Average Enrollment in Gestational Diabetes Trials by Phase
5.3 Average Enrollment in Gestational Diabetes Trials by Status
5.4 Average Enrollment in Gestational Diabetes Trials by Type of Trial
6. COMPANIES PARTICIPATING IN GESTATIONAL DIABETES CLINICAL TRIALS
6.1 Gestational Diabetes Trials by Sponsor Type
6.2 Gestational Diabetes Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Gestational Diabetes Trials- Phase
7.2 Gestational Diabetes Trials- Phase
7.3 Gestational Diabetes Trials- Phase
7.4 Gestational Diabetes Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Gestational Diabetes Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 5: Europe – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 7: North America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 9: Gestational Diabetes Clinical Trials by Phase
Figure 10: Gestational Diabetes Clinical Trials by Trial Status
Figure 11: Gestational Diabetes Clinical Trials by Type
Figure 12: Gestational Diabetes Clinical Trials by Sponsor Type
Figure 13: Gestational Diabetes Clinical Trials by Leading Sponsors
Figure 14: Gestational Diabetes Average Enrollment by Phase
Figure 15: Gestational Diabetes Average Enrollment by Trial Status
Figure 16: Gestational Diabetes Average Enrollment by Type
Figure 17: Gestational Diabetes- Average Enrolment by Type of Sponsors
Figure 18: Gestational Diabetes- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Gestational Diabetes Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 5: Europe – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 7: North America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Figure 9: Gestational Diabetes Clinical Trials by Phase
Figure 10: Gestational Diabetes Clinical Trials by Trial Status
Figure 11: Gestational Diabetes Clinical Trials by Type
Figure 12: Gestational Diabetes Clinical Trials by Sponsor Type
Figure 13: Gestational Diabetes Clinical Trials by Leading Sponsors
Figure 14: Gestational Diabetes Average Enrollment by Phase
Figure 15: Gestational Diabetes Average Enrollment by Trial Status
Figure 16: Gestational Diabetes Average Enrollment by Type
Figure 17: Gestational Diabetes- Average Enrolment by Type of Sponsors
Figure 18: Gestational Diabetes- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Gestational Diabetes Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 5: Europe – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 7: North America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gestational Diabetes Average Enrollment by Phase
Table 15: Gestational Diabetes Average Enrollment by Trial Status
Table 16: Gestational Diabetes Average Enrollment by Type
Table 17: Gestational Diabetes- Average Enrolment by Type of Sponsors
Table 18: Gestational Diabetes- Enrolment by Leading Sponsors
Table 1: Gestational Diabetes Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 5: Europe – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 7: North America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Gestational Diabetes Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gestational Diabetes Average Enrollment by Phase
Table 15: Gestational Diabetes Average Enrollment by Trial Status
Table 16: Gestational Diabetes Average Enrollment by Type
Table 17: Gestational Diabetes- Average Enrolment by Type of Sponsors
Table 18: Gestational Diabetes- Enrolment by Leading Sponsors
